B
Brian N. Bundy
Researcher at University of South Florida
Publications - 81
Citations - 16774
Brian N. Bundy is an academic researcher from University of South Florida. The author has contributed to research in topics: Gynecologic oncology & Carcinoma. The author has an hindex of 42, co-authored 77 publications receiving 15131 citations. Previous affiliations of Brian N. Bundy include University of Kansas Hospital & Roswell Park Cancer Institute.
Papers
More filters
Journal ArticleDOI
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
Deborah K. Armstrong,Brian N. Bundy,Lari Wenzel,Helen Q. Huang,Rebecca N. Baergen,Shashikant Lele,Larry J. Copeland,Joan L. Walker,Robert A. Burger +8 more
TL;DR: Quality of life was significantly worse in the intraperitoneal-therapy group before cycle 4 and three to six weeks after treatment but not one year after treatment, while survival in patients with optimally debulked stage III ovarian cancer improved.
Journal ArticleDOI
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
Peter G. Rose,Brian N. Bundy,E B Watkins,J T Thigpen,G Deppe,M A Maiman,Daniel L. Clarke-Pearson,S Insalaco +7 more
TL;DR: Regimens of radiotherapy and chemotherapy that contain cisplatin improve the rates of survival and progression-free survival among women with locally advanced cervical cancer.
Journal ArticleDOI
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
Eiichi Sato,Sara H. Olson,Jiyoung Ahn,Brian N. Bundy,Hiroyoshi Nishikawa,Feng Qian,Achim A. Jungbluth,Denise Frosina,Sacha Gnjatic,Christine B. Ambrosone,James L. Kepner,Tosin Odunsi,Gerd Ritter,Shashikant Lele,Yao-Tseng Chen,Haruo Ohtani,Lloyd J. Old,Kunle Odunsi +17 more
TL;DR: It is concluded that intraepithelial CD8+ TILs and a high CD8-/Treg ratio are associated with favorable prognosis in epithelial ovarian cancer.
Journal ArticleDOI
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma
Henry M. Keys,Brian N. Bundy,Frederick B. Stehman,Laila I. Muderspach,Weldon E. Chafe,Charles L. Suggs,Joan L. Walker,Deborah Gersell +7 more
TL;DR: Adding weekly infusions of cisplatin to pelvic radiotherapy followed by hysterectomy significantly reduced the risk of disease recurrence and death in women with bulky stage IB cervical cancers.
Journal ArticleDOI
Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A gynecologic oncology group study
C. Paul Morrow,Brian N. Bundy,Robert J. Kurman,William T. Creasman,Paul B Heller,Howard D. Homesley,James Graham +6 more
TL;DR: Data seem to implicate malignant cytology as a serious adverse finding, especially with respect to the risk for regional/distant and abdominal failure, in patients with negative surgical-pathological risk factors.